Chronic Chagas Cardiomyopathy Patients and Resynchronization Therapy: a Survival Analysis

Introduction: Chagas disease represents an important health problem with socioeconomic
impacts in many Latin-American countries. It is estimated that 20% to 30% of
the people infected by Trypanosoma cruzi will develop
chronic Chagas cardiomyopathy (CCC), which is generally accompanied by heart
failure (HF). Cardiac resynchronization therapy (CRT) may be indicated for
patients with HF and electromechanical dysfunctions.Objective: The primary endpoint of this study was to analyze the response to CRT in
patients with CCC, while the secondary endpoint was to estimate the survival
rates of CRT responder patients.Methods:

Source: Brazilian Journal of Cardiovascular Surgery - March 20, 2018 Category: Cardiology Source Type: research